e-learning
resources
Breathe
2021
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Challenging the paradigm: moving from umbrella labels to treatable traits in airway disease
Andrew Bush, Ian D. Pavord
Source:
Breathe, 17 (3) 210053; 10.1183/20734735.0053-2021
Journal Issue:
September
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Andrew Bush, Ian D. Pavord. Challenging the paradigm: moving from umbrella labels to treatable traits in airway disease. Breathe, 17 (3) 210053; 10.1183/20734735.0053-2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development?
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions
Source: Eur Respir J, 52 (3) 1800328; 10.1183/13993003.00328-2018
Year: 2018
A label-free approach to airways disease: phenotypes, endotypes and treatable traits
Source: ERS Research Seminar 2017 – Precision medicine in airway diseases
Year: 2017
Treatable traits: toward precision medicine of chronic airway diseases
Source: Eur Respir J 2016; 47: 410-419
Year: 2016
The role of cluster analysis in defining phenotypes of obstructive airway diseases: is there a need for a new taxonomy of obstructive airway diseases?
Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD
Year: 2011
Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?
Source: Eur Respir J, 49 (5) 1602397; 10.1183/13993003.02397-2016
Year: 2017
Asthma and chronic obstructive pulmonary disease training in an online environment: a new response to a growing problem
Source: International Congress 2019 – Nursing care across the spectrum of respiratory illnesses
Year: 2019
Rethinking the way we are treating established airway disease: current guidelines need to change
Source: International Congress 2016 – Presentation and discussion of a draft Lancet Commission on Asthma
Year: 2016
Interstitial lung disease: new challenges and evolving phenotypes
Source: Eur Respir Rev 2009; 19: 91-93
Year: 2010
Disturbed sleep and breathing disturbances in COPD and restrictive lung diseases: evidence gaps and challenges in diagnosis and treatment
Source: 5th Sleep and Breathing Conference
Year: 2019
Presentation by an expert: Emerging relationships between airway microbiota and chronic respiratory disease : mechanisms of disease onset
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013
NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice
Source: Eur Respir J, 58 (3) 2100627; 10.1183/13993003.00627-2021
Year: 2021
Mucosal cryobiopsies: A novel method for studying obstructive airways disease?
Source: International Congress 2017 – Innovation in COPD: techniques and facts
Year: 2017
What are the common biological mechanisms that lead to obstructive airway disease?
Source: International Congress 2016 – Early life origins of asthma and COPD
Year: 2016
Improving adherence in chronic airways disease: are we doing it wrongly?
Source: Breathe, 17 (2) 210022; 10.1183/20734735.0022-2021
Year: 2021
Treatment of severe stable COPD: the multidimensional approach of treatable traits
Source: ERJ Open Res, 6 (3) 00322-2019; 10.1183/23120541.00322-2019
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept